Surmodics, Inc. (SRDX)
NASDAQ: SRDX · Real-Time Price · USD
39.23
-0.39 (-0.98%)
Sep 11, 2024, 4:00 PM EDT - Market closed
Surmodics Employees
Surmodics had 376 employees as of September 30, 2023. The number of employees decreased by 71 or -15.88% compared to the previous year.
Employees
376
Change (1Y)
-71
Growth (1Y)
-15.88%
Revenue / Employee
$321,332
Profits / Employee
-$3,721
Market Cap
559.69M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AxoGen | 428 |
| Alector | 244 |
| UroGen Pharma | 201 |
| Arcturus Therapeutics Holdings | 180 |
| iTeos Therapeutics | 157 |
| Fulcrum Therapeutics | 76 |
| Celcuity | 55 |
| SIGA Technologies | 45 |
SRDX News
- 6 weeks ago - Surmodics Reports Third Quarter of Fiscal Year 2024 Financial Results - Business Wire
- 2 months ago - SURMODICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surmodics, Inc. - SRDX - Business Wire
- 3 months ago - Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc. - Business Wire
- 3 months ago - SURMODICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surmodics, Inc. - SRDX - Accesswire
- 3 months ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc. - PRNewsWire
- 3 months ago - Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million - Business Wire
- 4 months ago - Surmodics, Inc. (SRDX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance - Business Wire